1-247672557-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001005487.2(OR13G1):āc.485G>Cā(p.Arg162Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000332 in 1,613,948 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005487.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR13G1 | NM_001005487.2 | c.485G>C | p.Arg162Thr | missense_variant | 2/2 | ENST00000642119.1 | NP_001005487.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR13G1 | ENST00000642119.1 | c.485G>C | p.Arg162Thr | missense_variant | 2/2 | NM_001005487.2 | ENSP00000493110.1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251142Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135718
GnomAD4 exome AF: 0.000344 AC: 503AN: 1461832Hom.: 2 Cov.: 42 AF XY: 0.000331 AC XY: 241AN XY: 727210
GnomAD4 genome AF: 0.000217 AC: 33AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.485G>C (p.R162T) alteration is located in exon 1 (coding exon 1) of the OR13G1 gene. This alteration results from a G to C substitution at nucleotide position 485, causing the arginine (R) at amino acid position 162 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at